Loading...
XKRX
003120
Market cap119mUSD
Oct 08, Last price  
22,350.00KRW
1D
0.68%
1Q
10.64%
Jan 2017
-9.15%
Name

Ilsung Pharmaceutical Co Ltd

Chart & performance

D1W1MN
XKRX:003120 chart
P/E
137.30
P/S
2.49
EPS
162.78
Div yield, %
5.37%
Shrs. gr., 5y
11.64%
Rev. gr., 5y
9.63%
Revenues
64.29b
-6.85%
78,833,528,00079,870,404,00071,467,214,00068,594,693,00068,191,775,02077,160,760,62062,807,489,69062,828,920,56061,745,116,14067,463,384,16067,043,035,12061,652,595,25048,411,627,88040,600,732,00042,089,835,82061,247,847,00078,053,232,00069,018,341,00064,291,703,000
Net income
1.17b
-91.10%
17,699,848,00034,163,059,0008,049,787,0006,297,465,00035,083,007,47036,451,736,0807,955,018,2804,034,563,91098,853,930,9303,017,242,0402,628,652,9302,945,528,7406,718,550,3603,220,257,000-1,367,510,420108,669,346,000-20,940,893,00013,094,107,0001,165,835,000
CFO
17.28b
P
4,171,398,00016,535,708,0001,265,121,00018,644,306,0008,244,202,610-11,318,601,8705,063,947,6204,190,571,1006,041,134,630-31,013,469,62010,158,675,33015,091,217,1604,388,672,7101,557,299,0005,704,073,470-38,966,011,000-41,474,993,000-4,255,830,00017,278,670,000
Dividend
Dec 29, 20251200 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Ilsung Is Co., Ltd. is a South Korean pharmaceutical company established in 1961. The company specializes in the research, development, and manufacturing of medicines, with a historical focus on antibiotics. It also has products in areas such as cardiovascular treatments, anesthetics, and contrast media through in-licensing partnerships with global pharmaceutical firms.

Key people

Dae Sik Uhm
Co-Chief Executive Officer, Director · since 2025
Sang Eon Cho
Vice President · since 2022
Seon Ho Kim
Vice President · since 2024
Sang Hak Kim
Managing Director · since 2023
Yeong Min Kim
Assistant Managing Director · since 2023
Jong Ho Yoon
Co-Chief Executive Officer, Director · since 2025
Seok Geun Yoon
Co-Chief Executive Officer, Director · since 2025
Chan Wu Kang
Non-Executive Independent Director · since 2024
Seong Yeol Lee
Non-Executive Independent Director · since 2022
Chang Wan Son
Non-Executive Independent Director · since 2020
URL
https://www.ilsungis.com/
IPO date
Jan 14, 1985
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT